Anesthetic and Extracorporeal Management of Aortic Valve Replacement with Concurrent Oral Malignancy: A Case Report and Review of Literature

Advancement of medical management warrants the survival of cancer patients. Moreover, the cardiovascular abnormality is concurrently detected as a result of oncological therapy-induced cardiotoxicity, due to impaired immunity, prevailing infection or due to accelerated degeneration. Furthermore, extracorporeal circulation exaggerates the inflammatory and immunologic response, and therefore a potential challenge to anesthesia care giver. We hereby, describe anesthetic consideration of a patient with active oral malignancy posted for aortic valve replacement and also review extracorporeal perturbation in response to malignancy.